Effect of fluirbiprofen and lidocaine on sore throat due to the upper gastrointestinal system endoscopy

Effect of fluirbiprofen and lidocaine on sore throat due to the upper gastrointestinal system endoscopy: Randomized controlled study

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

PACTR

Registry ID

PACTR201901699494129

Enrollment

150

Registered

2019-01-25

Start date

2018-12-05

Completion date

Unknown

Last updated

2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ear, Nose and Throat Surgery Anaesthesia

Interventions

saline group

lidocaine group

Flurbiprofen group

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. 18-60 years of age elective endoscopy to be applied 2. American society of Anesthesia I-II 3. Mallampati I-II 4. Patients who have not undergone surgery 5. Patients have not received radiotherapy

Exclusion criteria

Exclusion criteria: 1. Patients who do not agree to participate in the study 2. Upper airway anomaly or infection 3. Smokers with sore throat 4. Endoscopes failed on first entry 5. Pregnant, those with drug allergy 6. Cases of emergency surgery, 7. Patients who have previously used Flurbiprofen 8. Patients without co-operation 9. Nazogastric catheter insertion

Design outcomes

Primary

Measure	Time frame
Find the incidence of sore throat due to the application of upper gastrointestinal system endoscopy and compare the effectiveness of lidocaine and flurbiprofen with the saline group	—

Secondary

Measure	Time frame
To evaluate possible side effects of lidocaine, flurbiprofen used in the treatment of sore throat due to upper gastrointestinal endoscopy	—

Countries

Somalia

Contacts

Public ContactSaamira Hassan

Miss.

samaara010@gmail.com+903124424240

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Feb 4, 2026